Skip to main content

Table 1 Participants' characteristics at first HAART visit

From: Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts

 

No history of injection drug use

History of injection drug use

No. ever reporting HAART

1,423

843

Study (% male):

  

   ALIVE

0 (NA)

269 (72%)

   MACS

597 (100%)

99 (100%)

   WIHS

826 (0%)

475 (0%)

Race/ethnicity:***

  

   Black, non-hispanic

35%

62%

   White, non-hispanic

45%

23%

   Hispanic

19%

14%

Median (IQR) nadir CD4 count (cells/mm 3 )***

187 (76–315)

152 (64–251)

Median (IQR) peak plasma HIV RNA (cps/ml)

90,606 (25,000–250,000)

84,000 (21,734–269,943)

High school education (vs less)***

74%

58%

Less than $10,000 legal income***

39%

72%

Currently employed***

47%

23%

Current smokers***

33%

73%

Current drinkers***

21%

28%

Ever prior AIDS diagnosis***

34%

45%

Year of HAART initiation***

  

   pre-1999

75%

62%

   1999–2001

16%

31%

   post-2001

9%

7%

HAART class

  

   PI/No NNRTI

61%

62%

   No PI/NNRTI

18%

18%

   PI/NNRTI

5%

5%

   No PI/No NNRTI

16%

15%

  1. ***p < 0.001